Investigating how GLP-1 receptor drugs affect asthma and inflammation.
Effects of GLP-1 Receptor Agonists on Airway Inflammation and Platelet Activation in Asthma
This study is looking at how a type of medication called GLP-1 receptor agonists might help people with asthma, especially those who also have issues with their metabolism, by reducing inflammation and improving their overall health without the side effects of usual asthma treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10892228 on NIH RePORTER |
What this research studies
This research explores the effects of GLP-1 receptor agonists on airway inflammation and platelet activation in patients with asthma, particularly those with metabolic dysregulation. The study aims to understand how these drugs can potentially reduce asthma symptoms and improve overall health by targeting metabolic pathways. By examining the relationship between platelet activation and asthma exacerbations, the research seeks to identify new treatment options that could spare patients from the side effects of traditional glucocorticoid therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with asthma who also have metabolic dysregulation or related conditions.
Not a fit: Patients who do not have asthma or metabolic dysregulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide new treatment options for asthma patients that minimize the need for glucocorticoids and improve their quality of life.
How similar studies have performed: Preliminary data suggests that similar approaches using GLP-1 receptor agonists have shown promise in reducing inflammation and improving outcomes in related conditions.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Foer, Dinah — Brigham and Women's Hospital
- Study coordinator: Foer, Dinah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.